TrialJournal of neurology, neurosurgery, and psychiatry2014

Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.

Tomas Olsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.